Skip to content
Open access · CC-BY via OpenAlex

Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma

Wenhan Cai, Miao Jing, Jiaxin Wen, Hua Guo, Zhiqiang Xue

Frontiers in Genetics · 2022 · ▲ 5 citations

Abstract

This study focused on the epigenetic alterations of DNA methylation and miRNAs for lung adenocarcinoma (LUAD) diagnosis and treatment using bioinformatics analyses. DNA methylation data and mRNA and miRNA expression microarray data were obtained from The Cancer Genome Atlas (TCGA) database. The differentially methylated genes (DMGs), differentially expressed genes (DEGs), and differentially expressed miRNAs were analyzed by using the limma package. The DAVID database performed GO and KEGG pathway enrichment analyses. Using STRING and Cytoscape, we constructed the protein–protein interaction (PPI) network and achieved visualization. The online analysis tool CMap was used to identify potential small-molecule drugs for LUAD. In LUAD, 607 high miRNA-targeting downregulated genes and 925 low miRNA-targeting upregulated genes, as well as 284 hypermethylated low-expression genes and 315 hypomethylated high-expression genes, were obtained. They were mainly enriched in terms of pathways in cancer, neuroactive ligand–receptor interaction, cAMP signaling pathway, and cytosolic DNA-sensing pathway. In addition, 40 upregulated and 84 downregulated genes were regulated by both aberrant alternations of DNA methylation and miRNAs. Five small-molecule drugs were identified as a potential treatment for LUAD, and five hub genes (SLC2A1,PAX6,LEP,KLF4, andFGF10) were found in PPI, and two of them (SLC2A1andKLF4) may be related to the prognosis of LUAD. In summary, our study identified a series of differentially expressed genes associated with epigenetic alterations of DNA methylation and miRNA in LUAD. Five small-molecule drugs and five hub genes may be promising drugs and targets for LUAD treatment.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3389/fgene.2022.817552
Canonical
link ↗
Fetched
2026-10-04 MST

Cite this

APA
Cai, W., Jing, M., Wen, J., Guo, H., &amp; Xue, Z. (2022). Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma. <em>Frontiers in Genetics</em>. https://doi.org/10.3389/fgene.2022.817552
Vancouver
Cai W, Jing M, Wen J, Guo H, Xue Z. Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma. Frontiers in Genetics. 2022. doi:10.3389/fgene.2022.817552.
BibTeX
@article{wenhan2022Epigen, title = {Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma}, author = {Wenhan Cai and Miao Jing and Jiaxin Wen and Hua Guo and Zhiqiang Xue}, journal = {Frontiers in Genetics}, year = {2022}, doi = {10.3389/fgene.2022.817552}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings